Stig Anders Lindberg

Affibody Medical AB provides biopharmaceuticals services. It develops Affibody, an antibody mimetic and Albumod, a technology that enhances the efficacy of biopharmaceuticals by extending their circulatory half-life through a strong binding to albumin. The company was founded by Karin Nord and Carl Erik Mathias Uhlén in 1998 and is headquartered in Stockholm, Sweden.

Investor Growth Capital AB (IGC) is a venture capital subsidiary of Investor AB founded in 1968. The firm is headquartered Stockholm, Sweden.

Amic AB develops in vitro diagnostic technologies for use in point-of-care diagnostic tests. Its technology uses a molded plastic device 4castchip & a optical detection system for precise and sensitive quantification of immunoassays. The company was founded in 1998 by Ove Öhman and is headquartered in Uppsala, Sweden

Newron Sweden AB is a biopharmaceutical company engaged in the development of novel therapies for the treatment of disorders of the central nervous systems. The company was founded by Jonas Cristopher Frisen and Ann Marie Janson in 1998 and is headquartered in Stockholm, Sweden.

Atlas Antibodies AB develops antibodies and reagents for Mass Spectrometry (MS)-based quantitative proteomics. Its project Human Protein Atlas aim to present an expression map of the complete human proteome. It offers characterized antibodies to various protein coding human genes; Triple A Polyclonals that are research grade rabbit polyclonal antibodies; and mouse monoclonal antibodies to selected proteins, as a complement to rabbit polyclonal antibodies. Its antibodies are used to study human proteins, for basic research purposes and clinical research in various disease areas, such as cancer and neurological brain diseases. The company was founded by Jan Fredrik Pontén, Karin Marianne Hansson, Henrik Wernérus, and Carl Erik Mathias Uhlén in 2006 and is headquartered in Stockholm, Sweden.

Dipylon Medical AB engages in the research and development of pharmaceutical products. The firm manufactures and sells products, materials and general medical instruments. It offers metabolic patient monitoring system. The company was founded on April 3, 1984 and is headquartered in Solna, Sweden.

Vårdapoteket i Norden AB owns and operates pharmacies. Its core business is to manage care-related pharmacies to offer the best possible service and product offering to patients and their relatives, and hospital staff. In addition, Vårdapoteket will also offer pharmaceutical supply, knowledge and ex tempore pharmaceutical services to hospitals. The company was founded by Bengt Emil Helge Åstrandin and Tony Stefan Rydberg 2009 and is headquartered in Malmö, Sweden.

Part of MiCo IVD Holdings, LLC, Fiomi Diagnostics AB is a Swedish company that develops, manufactures, and markets diagnostic test kits. The private company is based in Uppsala, Sweden. Fiomi Diagnostics was acquired by Trinity Biotech Plc on March 01, 2012 for $13.12 million.

Part of Getinge AB, Eirus Medical AB is a Swedish company that provides medical technology development services. The private company is based in Solna, Sweden. Eirus Medical was acquired by Getinge AB from Dipylon Medical AB on June 30, 2012 for $0.72 million.

Part of Alligator Bioscience AB, Atlas Therapeutics AB develops and manufactures antibody drugs. The private company is based in Stockholm, Sweden. Atlas Therapeutics was acquired by Alligator Bioscience AB on October 18, 2013.

Ginolis AB develops components in polymer by first producing the parts in original through different methods for sculpting silicon and glass wafers. These originals are transferred to molds in which the final components are manufactured through time-effective and thus economical favorable polymer replication processes. The polymers themselves, compared with silicon micromechanics, could also add material property advantages with the vast variety of materials available. They can with this platform serve many different fields all with the same need of precision and complexity. Ginolis AB has the skill and experience to integrate different functions onto the very same chip in order to achieve functions that, if they are at all possible to manufacture with traditional technique, needs several parts assembled to mechanical systems with higher cost for the parts as a consequence. These functions include nano- and microfludic channels, surface chemistry, electrical wave guides and connectors, refractive and diffractive micro-optics.

Part of Oncopeptides AB, Oncopeptides, Inc. is a private company committed to developing therapies for difficult-to-treat hematological diseases. The company is based in Waltham, MA. Oncopeptides strives to bring hope to patients through science and innovation, and is dedicated to bringing forward new and meaningful treatment options. The company is inspired by the perseverance of patients, caregivers, and healthcare providers in their fight against cancer. Oncopeptides' focus is on the development of therapies that can make a difference in the lives of those affected by hematological diseases.